Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.59 |
| ▸ | LTA4H | P09960 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 6/20 | 0.54 |
| ▸ | NPC1 | O15118 | 5/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | FLT3 | P36888 | 1/20 | 0.49 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.48 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL154088 | 0.98 | MAPT (0.61) | MAPTKDM4ELTA4HRAB9ANPC1 | |
| Formaldehyde SCHEMBL28193758 | 0.91 | MAPT (0.56) | MAPTKDM4ELTA4HRAB9ANPC1 | |
| SCHEMBL7455134 | 0.88 | LTA4H (0.67) | MAPTKDM4ELTA4HRAB9ANPC1 | |
| SCHEMBL338810 | 0.85 | LTA4H (0.70) | MAPTKDM4ELTA4HRAB9ANPC1 | |
| SCHEMBL9931968 | 0.85 | MAPT (0.50) | MAPTKDM4ELTA4HRAB9ANPC1 | |
| Toluene SCHEMBL28225957 | 0.85 | KDM4E (0.58) | MAPTKDM4ELTA4HRAB9ANPC1 | |
| SCHEMBL10472190 | 0.84 | HSD17B1 (0.51) | MAPTKDM4ELTA4HRAB9ANPC1 | |
| SCHEMBL559934 | 0.81 | LTA4H (0.59) | MAPTKDM4ELTA4HHPGDALDH1A1 | |
| SCHEMBL7058736 | 0.81 | LTA4H (0.59) | MAPTKDM4ELTA4HHPGDALDH1A1 | |
| SCHEMBL1464252 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2518075-A1 | INDUCED LAYER MATERIAL FOR PREPARING NON-PLANAR METAL PHTHALOCYANINE WEAK EPITAXY GROWTH THIN FILM | Shanghai Casail Display Technology Ltd. (CN) | 2012-10-31 | — | — | EP | disclosed |
| EP-2518075-A1 | INDUCED LAYER MATERIAL FOR PREPARING NON-PLANAR METAL PHTHALOCYANINE WEAK EPITAXY GROWTH THIN FILM | Shanghai Casail Display Technology Ltd. (CN) | 2012-10-31 | — | — | EP | disclosed |
| US-20110152541-A1 | INDUCING LAYER MATERIALS FOR WEAK EPITAXIAL FILMS OF NON-PLANAR METAL PHTHALOCYANINE | SHANGHAI CASAIL DISPLAY TECHNOLOGY LTD. (CN) | 2011-06-23 | — | — | US | disclosed |
| US-20110152541-A1 | INDUCING LAYER MATERIALS FOR WEAK EPITAXIAL FILMS OF NON-PLANAR METAL PHTHALOCYANINE | SHANGHAI CASAIL DISPLAY TECHNOLOGY LTD. (CN) | 2011-06-23 | — | — | US | disclosed |
| US-20110152541-A1 | INDUCING LAYER MATERIALS FOR WEAK EPITAXIAL FILMS OF NON-PLANAR METAL PHTHALOCYANINE | SHANGHAI CASAIL DISPLAY TECHNOLOGY LTD. (CN) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152541-A1 | INDUCING LAYER MATERIALS FOR WEAK EPITAXIAL FILMS OF NON-PLANAR METAL PHTHALOCYANINE | CDYL, PAX3, PAXBP1 | MAPT 2446/4885KDM4E 93/4885LTA4H 4523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.